Clinic
Advanced Spine and Pain Centers, INC.
Advanced Spine and Pain Centers, INC. was paid $3.57M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 64636, — 42% of everything it billed.
33Billing provider infoADVANCED SPINE AND PAIN CENTERS, INC.
LITTLE ROCK, AR 72211
LITTLE ROCK, AR 72211
33aNPI1619219433assigned 03/19/2013
33bProvider typePain Clinic/Center
28Total paid$3.57M
24GClaims36,600
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pain Clinic/Center providers in Arkansas
Rank by total paid#1 of 6
Median peer was paid$31K
This provider vs. median116×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,733 | $955K | |
| 2019 | 8,272 | $653K | |
| 2020 | 5,121 | $421K | |
| 2021 | 3,650 | $247K | |
| 2022 | 4,643 | $711K | |
| 2023 | 2,963 | $336K | |
| 2024incomplete | 3,218 | $244K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 64636 | 42% | 1,851 | 1,379 | $1.48M | |
| 64635 | 24% | 1,847 | 1,378 | $846K | |
| L0648 | Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | 11% | 710 | 611 | $394K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.9% | 13,738 | 11,596 | $317K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.4% | 4,943 | 4,425 | $194K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.0% | 1,769 | 1,565 | $70K |
| 80332 | 1.2% | 2,391 | 2,104 | $42K | |
| 80338 | 1.1% | 2,375 | 2,090 | $41K | |
| 80324 | 1.0% | 2,430 | 2,114 | $37K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 832 | 714 | $34K |
| 62323 | <1% | 157 | 140 | $30K | |
| 64493 | <1% | 192 | 158 | $22K |
38 more codes
| L0637 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 32 | $18K |
| 99152 | <1% | 587 | $15K | |
| 64495 | <1% | 192 | $8K | |
| 64494 | <1% | 192 | $8K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 79 | $1K |
| 80347 | <1% | 84 | $1K | |
| 80364 | <1% | 84 | $1K | |
| 20552 | <1% | 16 | $875.05 | |
| 80370 | <1% | 84 | $868.68 | |
| 80368 | <1% | 126 | $718.78 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 611 | $711.10 |
| 83992 | <1% | 55 | $139.44 | |
| 80356 | <1% | 13 | $125.94 | |
| 80358 | <1% | 55 | $67.04 | |
| 80355 | <1% | 56 | $65.34 | |
| 80361 | <1% | 55 | $41.98 | |
| 80365 | <1% | 55 | $27.02 | |
| 80359 | <1% | 55 | $24.45 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 17 | $8.48 |
| 80363 | 0% | 42 | $0.00 | |
| 80333 | 0% | 42 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 58 | $0.00 |
| 80350 | 0% | 42 | $0.00 | |
| 80353 | 0% | 42 | $0.00 | |
| 80367 | 0% | 55 | $0.00 | |
| 80345 | 0% | 13 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 198 | $0.00 |
| 80354 | 0% | 42 | $0.00 | |
| 80346 | 0% | 42 | $0.00 | |
| 80372 | 0% | 52 | $0.00 | |
| 80373 | 0% | 55 | $0.00 | |
| 80336 | 0% | 49 | $0.00 | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 18 | $0.00 |
| 80369 | 0% | 42 | $0.00 | |
| 80366 | 0% | 42 | $0.00 | |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 16 | $0.00 |
| 80348 | 0% | 39 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSALEEM, MAJID (PHYSICIAN/OWNER)